vasoactive

vasoactive

1. Nitrogen monoxide (NO) as a vasoactive peptide with many kinds of biological activity is an important regulatory factor for the self-regulation of eye vessels.

一氧化氮(NO)是具有多种生物活性的血管活性物质,是眼部血管自我调节的一个重要调节因子。

2. Effects of nitric oxide and vasoactive intestinal polypeptide in experimental reflux esophagitis

一氧化氮及血管活性肠肽在实验性反流性食管炎发病机制中的作用

3. Observation on plasma vasoactive intestinal polypeptide in patients with trigeminal neuralgia

三叉神经痛患者血浆血管活性肠多肽的观察

4. Distribution of nitric oxide synthase and vasoactive intestinal peptide in the gastrointestine of mandarin vole Microtus mandarinus under different energy demands

不同能量需求的棕色田鼠胃肠道一氧化氮合酶和血管活性肠肽的分布

5. Keywords _（dbc）AMP-Ca Cerebral hemorrhage;Internal capsule Plasma Pituitary Ade nylate Cyclase Activiting Poly-peptide Vasoactive intestinal peptide Gastric ulcer Stress;

二丁酰环腺苷酸;脑出血;内囊;血浆;垂体腺苷酸环化酶激活肽;血管活性肠肽;胃溃疡;应激;

6. 6 Dubourg A,Scamuffa RF.An experimental overview of a new vasoactive drugs:buflomedil HCI.Angiology,1981,32:663.

亚低温联合丁咯地尔防治脑出血后缺血性脑损害的临床观察研究由800论文网收集整理，转载请注明出处！

7. LIGHT AND ELECTRON MICROSCOPIC STUDY OF THE RELATIONSHIP OF THE SUBSTANCE P AND VASOACTIVE INTESTINAL POLYPEPTIDE IMMUNOREACTIVE NERVE FIBRES WITH MAST CELLS ON MERIDIAN LINE IN HUMAN SKIN

人皮肤经络线上P物质和VIP免疫反应神经纤维与肥大细胞关系的光镜和电镜研究

8. Effect of Electroacupuncture on Bladder Hyperactivity and Its Relation with the Activity of the Spinal Vasoactive Intestinal Peptide and Pontine Tyrosine Hydroxylase in the Rat

从血管活性肠肽、酪氨酸羟化酶研究电针抑制左旋多巴诱发大鼠膀胱机能亢进的神经生物学机制

9. The efficiency was much better when intracavernous vasoactive drug injection (ICI) was used.

使用海绵体注射血管活性药物的患者改善比例更高,达15/17。

10. Effects of enalapril on plasma vasoactive substances and cell cation transport in elder patients with essential hypertension

依那普利对老年高血压病患者血管活性物质和细胞离子转运的影响

11. Changes of anorectal motility and serum vasoactive intestinal polypeptide in patients with chronic constipation

便秘的肛门直肠动力和血浆活性肠肽变化的研究

12. Effect of recombinant human erythropoietin on vasoactive substances in aged maintenance haemodialysis patients

促红细胞生成素对老年血液透析患者血管活性介质的影响

13. Influence of Liujunzijiajian Formula on vasoactive fractious of gastric mucous coat in rats with gastric ulcer

六君子加减方对胃溃疡大鼠胃黏膜血管活性物质的影响

14. Keywords Pericarpium arecae;Motilin;Substance P;Vasoactive in testinal peptide;Gastric emptying;

关键词大腹皮;胃动素;P物质;血管活性肠肽;胃动力;

15. Keywords form deprivation myopia;vasoactive intestinal peptide receptor 2/analysis;chickens;reveres transcriptase polymerase chain reaction/methods;

关键词形觉剥夺性近视;血管活性肠肽受体2亚型/分析;鸡;逆转录聚合酶链反应/方法;

16. Keywords Aerobatics Galanin Endothelin Vasoactive intestinal peptide;

关键词特技飞行;甘丙素;内皮素;血管活性肠肽;

17. Keywords gastric motility disorder;vasoactive intestinal peptide;electric acupuncture;

关键词胃动力紊乱;血管活性肠肽;电针;

18. Keywords fetal;thymus;diffuse neuroendocrine system;chromogranin A;neuron specific enolase;somatostatin;vasoactive intestinal peptide;

关键词胎儿;胸腺;弥散神经内分泌系统;嗜铬素A;神经元特异性烯醇化酶;生长抑素;血管活性肠肽;

19. endothelium-derived vasoactive factor

内皮衍生的血管活性因子

20. Keywords coronary artery disease;hyperlipemia;vasoactive peptide;Jiangzhi Tongmai recipe;

冠心病;高脂血症;血脂;血管活性肽;降脂通脉方;

21. Expression of Vasoactive Intestinal Peptide mRNA in Gastric Antral Mucosa of Patients with Functional Dyspepsia

功能性消化不良患者胃窦黏膜血管活性肠肽mRNA的表达

22. Keywords Jiawei Sijunzi Decoction;Spleen Deficiency Syndrome;ileum;substance P;vasoactive intestinal peptides;electric mechanical activity;

加味四君子汤;脾虚证;回肠;P物质;血管活性肠肽;电-机械活动;

23. Keywords Acceleration;Galanin;Endothelin;Vasoactive intestinal peptide;

加速度;甘丙素;内皮素;血管活性肠肽;

24. Keywords Captopril;Enflurane;Ventrotomy;Hemodynamics;Vasoactive substances;

卡托普利;安氟醚;剖腹术;循环;血管活性物质;

25. Changes of Cardiac Tissue Characteristics and Levels of Partial Plasma Vasoactive Peptides in Essential Hypertension After Carvedilol Administration

卡维地洛对原发性高血压心肌组织特征及部分血管活性肽水平的改变

26. Content of plasma vasoactive substances in hypertensive patients with different risk stratifications and the influence of medicine

原发性高血压不同危险度分层中血管活性物质的水平及药物治疗的影响

27. Quantitative variation of vasoactive intestinal polypeptide and its receptor in rat liver during development

发育过程中肝脏血管活性肠肽及其受体量的变化

28. Plasma concentration of endothelial vasoactive factors and their clinical significance in patients with peripheral arterial occlusive disease

周围动脉闭塞性疾病血管内皮活性物质水平的意义

29. Thus, vasoactive serotonin supports virus persistence in the liver and aggravates virus-induced immunopathology.

因此，5-羟色胺能使病毒在肝脏持续感染，并导致肝脏病理性炎症加重。

30. Effects of compound purslane on lipid peroxidation and vasoactive peptide of patients with coronary atherosclerotic heart disease complicated with hyperviscosity

复方马齿苋对冠状动脉粥样硬化性心脏病高黏血症患者脂质过氧化及血管活性肽的影响

31. Known vasoactive substance blockers could not alter the effect of AHF on BP. These data indicated that the effect of AHF on BP might be mediated via a specific receptor.

多种已知的血管活性物质的特异受体拮抗剂只能阻断其相应的血管活性物质对血压的作用，对AHF的降压活性无影响。

32. Changes of Vasoactive Intestinal Peptide in Plasma and Stomach Organizes of Rat with Gastric Stress Ulcers Induced by Internal Capsule Hemorrhage

实验性大鼠内囊出血并应激性胃溃疡时血浆胃组织匀浆中血管活性肠肽含量变化及意义

33. Changes and clinical significance of Pituitary Adenylate Cyclase Activating Poly-peptide and vasoactive intestinal peptide in plasma and stomach tissues of rats with gastric stress ulcers induced by internal capsule hemorrhage

实验性大鼠内囊出血并应激性胃溃疡血浆和胃组织中垂体腺苷酸环化酶激活肽及血管活性肠肽含量变化及意义

34. Keywords Oligonucleotides（ON） Radioiodinated Vasoactive intestinal peptide receptor Antisense therapy;

寡核苷酸;放射性碘标记;血管活性肠肽受体;反义治疗;

35. Meanwhile, the plasma levels of substance P (SP) and vasoactive intestinal peptide (VIP) in 15 patients and 13 healthy subjects were measured using radioimmunoassay (RIA).

对15例银屑病患者与13名健康人血浆中P物质(SP)、血管活性肠肽(VIP)的含量进行放射免疫测定。

36. Influence of Berberine on Vasoactive Substances of Gastric Mucous Coat in Mice with Gastric Ulcer

小檗碱对胃溃疡小鼠胃黏膜血管活性物质的影响

37. intestinal vasoactive polypeptide

小肠血管活性多肽

38. Keywords Anisodamine;Internal capsule hemorrhage;Pituitary adenylate cyclase activiting poly-peptide;Vasoactive intestinal peptide;Gastric stress ulcers;

山莨菪碱;内囊出血;垂体腺苷酸环化酶激活多肽;血管活性肠肽;应激性溃疡;

39. Vasoactive Intestinal Peptide(VIP) antigen in the medulla of Wanxi white Goose has been detected by using immunohistoche-mical SABC method.

应用免疫组织化学SABC染色法,对血管活性肠肽(VIP)免疫反应阳性细胞在皖西白鹅延髓内的分布进行了观察。

40. Changes and its significance of plasma vasoactive intestinal peptide in congestive heart failure

心力衰竭患儿血浆血管活性肠肽的变化及其临床意义

41. Influence of acute hypoxia on the releases of Substance P(SP)and vasoactive intestinal polypeptide(VIP)from the cats lung

急性缺氧对肺脏释放P物质血管活性肠肽的影响

42. A little extra Vasoactive Peptide in the Cerebellum?

抑或是小脑中的一些额外的血管活性肽作用了？

43. Changes of vasoactive factors in lung tissue of newborn piglets with persistent pulmonary hypertension and effect of magnesium sulphate

持续肺动脉高压新生猪肺组织血管活性因子的变化及硫酸镁对其的影响

44. To study the role of vasoactive intestinal polypeptide-like(VIP-LI) nerve fibers innervatingmiddle cerebral artery (MCA)during cerebral ischemia.

探讨支配脑血管的血管活性肠肽(VIP)样神经纤维在脑缺血中的作用。

45. Objective To investigate the effects of Tianshu capsule on vasoactive substances in blood plasma or brain and hemodynamics in migraine animal models.

摘要目的研究天舒胶囊对偏头痛动物模型血浆及脑组织血管活性物质及血流动力学的影响。

46. Calcitonin Gene-related peptides and Vasoactive Intestinal Peptide in Plasma and Lesion of Patients with Alopecia Areata

斑秃患者血浆和皮损中降钙素基因相关肽、血管活性肠肽的研究

47. Changes of plasma vasoactive intestinal polypeptide in asphyxial newborn and effects of naloxone on it

新生儿窒息血浆血管活性肠肽的变化及纳洛酮对其影响的研究

48. Effect of vasoactive intestinal polypeptide and naloxone in children of hypoxic-ischemic en Cephalopathy

新生儿缺氧缺血性脑病血浆血管活性肠肽的变化及纳洛酮对其的影响

49. Plasma and cerebrospinal fluid levels of somatostatin and vasoactive intestinal polypeptide in newborns with intracranial hemorrhage

新生儿颅内出血患者血浆、脑脊液中生长抑素和血管活性肠肽的测定及意义

50. Dynamic changes in levels of vasoactive intestinal peptide and adrenocorticotropic hormone in the brain after hypoxic ischemic brain injury

新生大鼠缺氧缺血性脑损伤后脑内血管活性肠肽和促肾上腺皮质激素的动态变化

51. Methods The levels of gastin,motilin and vasoactive intestinal polypoptide of 31 TPN and 33 PPN preterm infants were measured by RIA at ages of 1,3,7, and 10 days.

方法对31例全静脉内营养和33例部分肠道内喂养的早产儿，分别在生后的第1、3、7、10天进行血清胃泌素、胃动素、血管活性肽水平的测定。

52. Methods Literatures concerning metabolism, rece ptors, action mechanisms of vasoactive mediators and their effects in AP were re viewed.

方法采用文献回顾的方法,对涉及血管活性物质的代谢、受体、作用机理和在急性胰腺炎中所起作用的研究进行了综述。

53. Keywords Hypertension;Circadian rhythm;Catecholamine;Reninangiotensin-aldosterone system;Chronobiology;Light;Endothelial vasoactive substance;Blood pressure;

时间生物学;生物节律;肾素-血管紧张素-醛固酮系统;内皮源性血管活性物质;儿茶酚胺;

54. Keywords Areca nut;functional dyspepsia;motilin;vasoactive intestinal peptide;rat;

槟榔;功能性消化不良;胃动素;血管活性肽;大鼠;

55. positive vasoactive agents

正性血管活性药物

56. Keywords muscarinic acetylcholine receptor;vasoactive intestinal polypeptide;form-deprived myopia;retina;sclera;myopia;PRK;LASIK;refraction;stability;

毒蕈碱型乙酰胆碱受体;血管活性肠肽;形觉剥夺性近视;视网膜;巩膜;近视;PRK;LASIK;屈光;稳定性;

57. Effect of Qixuebingzhifang Extract on Vasoactive Substance and Activating Blood Circulation in Hyperlipidemia and Blood Stasis Rats

气血并治方及其配伍对高脂血症血瘀大鼠血管活性物质的影响

58. Effect of Water Bath Extractive Drug Couples of Complex Prescription of Treating both Gas and Blood on Hemorheological Characteristic and Vasoactive Substance in Rats

气血并治方水溶性提取物对正常大鼠血液流变性和血管活性物质的影响

59. Keywords Principle and Therapy;Diabetes mellius（DM）;Vascular endothelial cell（VEC）;Vasoactive substance;

治则治法;糖尿病;血管内皮细胞;血管活性物质;

60. Keywords DYSPEPSIA/TCD therapy;SHUGAN JIANPI PRESCRIPTION/therapeutic use;GASTRIC EMPTYING/drug effects;VASOACTIVE INTESTINAL PEPTIDE/blood;

消化不良/中药疗法;疏肝健脾方/治疗应用;胃排空/药物作用;血管活性肠肽/血液;

61. Keywords Substance P;Vasoactive intestinal peptide;Sacculus Rotundus of rabbits;intestinal mucosal immunity;

物质;血管活性肠肽;兔圆小囊;肠道黏膜免疫;

62. Keywords substance P;vasoactive intestinal peptide;lichen planus;

物质;血管活性肠肽;扁平苔藓;

63. Influence of the Recipe of Soothing the Liver and Regulating the Stomach on the Nitric Oxide Synthase and Vasoactive Intestine Peptide of Rats with Mixed Reflux Esophagitis

疏肝和胃方对混合反流性食管炎大鼠一氧化氮合酶和血管活性肠肽的影响

64. Preventive and curative effect of Shugan Huoxue Jianpi formula on gastrin and vasoactive intestinal peptide of stomach tissues in rats with portal hypertensive gastropathy

疏肝活血健脾方对门脉高压性胃病大鼠胃肠激素的影响及防治作用

65. AIM:To probe into relation beween unstable angina pectoris (UAP) and vasoactive peptide.

目的:探讨不稳定性心绞痛(UAP)与血管活性肽的相关性。

66. Objective:To explore the status of vasoactive neuropeptides and opioid peptides during migraine attack.

目的:探讨与血管舒缩有关的神经肽以及类阿片肽在偏头痛发病中的主次作用。

67. Objective:To investigate the effect of Buchang Naoxintong(NXT) on the level of vasoactive intestinal peptide(VIP) in plasma and hypothalamus in rats with middle cerebral artery infarction.

目的:研究步长脑心通对中动脉局灶性栓塞模型大鼠血浆及下丘脑组织血管活性肠肽的影响。

68. Objective:To investigate the distribution of Substance P(SP),Vasoactive intestinal peptide(VIP),and neuropeptideY(NPY) in the thymus of rats and their relations to the development of T lymphocytes.

目的:观察P物质(SP)、血管活性肠肽(VIP)和神经肽Y(NPY)在大鼠胸腺的分布及与T细胞发育的关系。

69. Objective:The aim of this study was to observe whether vasoactive intestinal polypeptide (VIP) participated in the attack of trigeminal neuralgia, and to understand further its pathogenetic mechanism.

目的:观察三叉神经痛发作时临近原发病灶的静脉血中是否有血管活性肠肽(VIP)的参与。

70. Objective: To observe the distribution of nerves containing vasoactive intestinal peptide(VIP) in the reptile: cloaca wall of Alligator sinensis.

目的:观察含血管活性肠肽(VIP)神经在爬行类动物扬子鳄泄殖腔壁内的分布特点。

71. Objective To summarize the effects of vasoactive mediators on local microvasculature in acute pancreatitis(AP).

目的探讨血管活性物质在急性胰腺炎微循环障碍中的作用。

72. Objective To investigate the function of vasoactive intestinal peptide(VIP) in pathogenesis of LP.

目的探讨血管活性肠肽(VIP)在扁平苔藓(LP)发病中的作用。

73. Objective To study the role of vasoactive intestinal peptide (VIP) in the pathogenesis of psoriasis.

目的探讨血管活性肠肽(VIP)在银屑病发病中的作用。

74. Objective To study the content of vasoactive intestinal peptide in detrusor of the bladder.

目的研究反射亢进型神经性膀胱逼尿肌中血管活性肠肽的含量变化,探讨其对膀胱功能的影响。

75. Objective To observe whether vasoactive intestinal polypeptide(VIP) participates in the attack of trigeminal neuralgia, and get a deeper understanding about its pathogenetic mechanism.

目的观察三叉神经痛发作时局部是否有血管活性肠多肽(VIP)的参与,加深对三叉神经痛发病机制的认识。

76. Objective: To establish a canine model of portal hypertension with esophageal varices, and explore the effects of somatostatin and octreotide on portal pressure and vasoactive substance.

目的：建立门脉高压食道静脉曲张杂交犬模型，探讨生长抑素及奥曲肽对动物模型门静脉压力和血管活性物质的影响。

77. Objective: To investigate etiological roles of vasoactive substances in cerebral vasc ular diseases.

目的：探讨血管活性物质在脑血管病发病中的作用。

78. Purpose: Some studys had show that pylorus stenosis is due to the absent of NOS and Vasoactive intestinal peptide(VIP) nerves in pylorus sphincter, in this study.

目的：既往的研究表明幽门括约肌的收缩与舒张受胆碱能神经、肾上腺素能神经、多肽能神经和NOS神经的调节。

79. Keywords Rhizoma Acori Tatarinowii;Radiz Paeoniae Rubra;ethanolic extract;depression;vasoactive intestinal polypeptide;substance P;

石菖蒲;赤芍;醇提物;抑郁症;血管活性肠肽;P物质;

80. Keywords Amomum Villosum;Gastrointestinal motility;Motilin;Substance P;Vasoactive intestinal peptide;

砂仁;胃肠活动;胃动素;P物质;血管活性肠肽;